Baxter International Inc. (NYSE:BAX) agreed to acquire compounding business and related assets of Hospira UK Limited on October 18, 2018. The transaction is subject to the approval of The Competition and Markets Authority. As of December 13, 2018, the deal has been approved by CMA. Results Healthcare acted as financial advisor to Hospira. Baxter International Inc. (NYSE:BAX) completed the acquisition of compounding business and related assets of Hospira UK Limited on January 4, 2019.